+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global In-Vitro Fertilization (IVF) Market (2023-2028) by Instrument, Technology, End-User, Geography, Competitive Analysis and the Impact of Economic Slowdown & Impending Recession with Ansoff Analysis

  • PDF Icon


  • 153 Pages
  • May 2023
  • Infogence Global Research
  • ID: 5635516

Various Policies That Promote Improved Insurance Coverage are Bound to Lower the Cost of IVF to Patients and Increase its Utilization


The Global In-Vitro Fertilization (IVF) Market is estimated to be USD 19.78 Bn in 2023 and is expected to reach USD 31.1 Bn by 2028, growing at a CAGR of 9.47%.

  • In vitro fertilization (IVF) is a complex series of procedures used to help with fertility or prevent genetic problems and assist with the conception of a child. During IVF, mature eggs are collected from ovaries and fertilized by sperm in a lab.
  • According to WHO, around 17.5% of the adult population -1 in 6 worldwide - experience infertility, increasing the demand for fertility treatments. The increasing prevalence of infertility is expected to drive the demand for IVF. The increase in prevalence is majorly due to people's hectic and sedentary lifestyles. In addition, an increase in the trend of delayed childbearing and growing medical conditions contribute to infertility, prompting individuals and couples to seek assisted reproductive technologies.
  • Growing awareness about infertility and available treatment options, including IVF by the government and organizations, has further contributed to increased demand. The awareness of changing societal aspects has also contributed to the demand for IVF. As more individuals and couples seek to start or expand their families, IVF becomes attractive.
  • However, the low success rate of IVF is majorly hindering market growth. Only 33% of people undergoing IVF get pregnant during their first IVF cycle. And by the eighth cycle, around 54-77% of women undergoing IVF get pregnant. In addition, the high cost of IVF procedures further impacts the market growth. 
  • Advances in IVF techniques such as AI in IVF, Stem Cell Treatment, Laser Assisted Hatching, and Robotic Technology and Nanobots, including improved success rates, are expected to create market opportunities. 
  • In cases where same-sex male couples or single individuals are involved, donor eggs and gestational surrogacy may be used to create embryos, offering these individuals or couples a chance to become parents, growing the IVF demand. 

The government approval of removing genetic abnormalities is expected to create opportunities for the market further. This testing allows the identification of genetic abnormalities or chromosomal disorders in embryos before they are transferred to the uterus. It can help reduce the risk of passing on certain genetic conditions to the offspring.

Market Segmentations

The Global In-Vitro Fertilization Market is segmented based on Component, Technology, Origin of Embryos, End-User, and Geography. 
By Component, the market is classified into Equipment and Reagent & Media. The Equipment segment is anticipated to hold the largest market share in the forecasting period due to the high cost of the equipment and the major component of In-vitro fertilization. IVF laboratories require specific equipment to support the various steps involved in the IVF process. This includes equipment for controlled incubation and culture of embryos. The demand for such equipment has risen with the increased demand for IVF procedures.

By Technology, the market is classified into Conventional IVF, Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Testing (PGT), and Others. Conventional IVF holds the major market share in the market since conventional IVF is the most commonly used form of assisted reproductive technology. Conventional IVF has a high demand due to its effectiveness in treating various causes of infertility, including ovulation disorders, blocked fallopian tubes, endometriosis, male factor infertility, and unexplained infertility.

By Origin of Embryos, the market is classified into Fresh Non-donor, Frozen Non-donor, Frozen Donor, and Fresh Donor. The Fresh Non-donor segment holds the major market share because it is the most common and accessible option for couples or individuals undergoing IVF treatment. It allows for a more personalized approach, utilizing the patient's eggs and sperm.

By End User, the market is classified into Cryobanks, Fertility Clinics, and Hospitals. The fertility clinics segment holds a major market share as they are specialized healthcare facilities that offer a wide range of reproductive services, including IVF treatments. These clinics are at the forefront of the IVF industry, providing comprehensive fertility care, from initial consultations and diagnostic testing to the actual IVF procedures. They are directly involved in conducting IVF cycles and providing the necessary expertise and support. In addition, increasing fertility clinics worldwide are expected to create opportunities for the segment. 

By Geography, the market is classified into the Americas, Europe, Middle East & Africa, and Asia-Pacific. The Asia Pacific region holds the largest market share in the forecasting period due to the large patient pool and increases in medical tourism in the region. Moreover, the increasing awareness and acceptance of IVF procedures are driving the demand for the IVF market in the APAC region. 

Recent Development

SymphonyAI acquired NetReveal from BAE Systems. This acquisition marks a significant step in SymphonyAI’s expansion strategy within the financial vertical. - July 2022
Software Ag announced an agreement to acquire StreamSets, a leader in data integration for the modern data stack. - Feb 2022

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Corning Inc., Esco Micro Pte. Ltd., FUJIFILM Irvine Scientific, Inc., Hamilton Thorne, Inc., Irvine Scientific, etc. 

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of the Americas) 
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe) 
  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA) 
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific) 

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. 

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global In-Vitro Fertilization Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. 
  • The publisher analyses the Global In-Vitro Fertilization Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. 
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth. 

Why buy this report? 

  • The report offers a comprehensive evaluation of the Global In-Vitro Fertilization Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies. 
  • The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies. 
  • An Excel data sheet for the market size will also be provided with the report.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
  • The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies. 
  • The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors.
  • The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
  • Market segmentation
  • Competitive Analysis: Comparative analysis of competitor
  • The historical, current, and projected size of the market based on value and volume
  • The market size of the US states 
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

This product will be delivered within 2 business days.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Publisher Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook

4 Market Dynamics
4.1 Impact Analysis
4.2 Drivers
4.2.1 Rising Cases of Infertility
4.2.2 People Inclined Toward Unhealthy & Hectic Lifestyles
4.2.3 Government Initiatives to Promote IVF Treatments
4.3 Restraints
4.3.1 High Costs Associated With IVF Procedures
4.3.2 Low Success Rate to IVF Treatment
4.4 Opportunities
4.4.1 Introduction of New Advanced Technology
4.4.2 Increasing Awareness and Accessibility of IVF Technology in Developing Areas
4.4.3 Rising Trend of Fertility Tourism
4.5 Challenges
4.5.1 Availability of Alternative Methods
4.5.2 Ethical Concern in Society for Acceptance of IVF

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis

6 Global In-Vitro Fertilization Market, By Component
6.1 Introduction
6.2 Equipment
6.2.1 Imaging Systems
6.2.2 Sperm Separation Systems
6.2.3 Ovum Aspiration Pumps
6.2.4 Micromanipulator Systems
6.2.5 Gas Analyzers
6.2.6 Laser Systems
6.2.7 Cryptosystems
6.2.8 Cabinets
6.2.9 Anti-Vibration Tables
6.2.10 Witness Systems
6.2.11 Accessories
6.3 Reagent & Media
6.3.1 Embryo Culture Media
6.3.2 Cryopreservation Media
6.3.3 Sperm Processing Media
6.3.4 Ovum Processing Media

7 Global In-Vitro Fertilization Market, By Technology
7.1 Introduction
7.2 Conventional IVF
7.3 Intracytoplasmic Sperm Injection (ICSI)
7.4 Preimplantation Genetic Testing (PGT)
7.5 Others (Frozen Embryo Transfer (FET), Blastocyst Transfer, Assisted Hatching)

8 Global In-Vitro Fertilization Market, By Origin of Embryos
8.1 Introduction
8.2 Fresh Non-Donor
8.3 Frozen Non-Donor
8.4 Frozen Donor
8.5 Fresh Donor

9 Global In-Vitro Fertilization Market, By End User
9.1 Introduction
9.2 Cryobanks
9.3 Fertility Clinics
9.4 Hospitals

10 Americas' In-Vitro Fertilization Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas

11 Europe's In-Vitro Fertilization Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Ireland
11.10 Luxembourg
11.11 Netherlands
11.12 Norway
11.13 Poland
11.14 Russia
11.15 Spain
11.16 Sweden
11.17 Switzerland
11.18 United Kingdom
11.19 Rest of Europe

12 Middle East and Africa's In-Vitro Fertilization Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Nigeria
12.6 Saudi Arabia
12.7 South Africa
12.8 United Arab Emirates
12.9 Rest of MEA

13 APAC's In-Vitro Fertilization Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific

14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis

15 Company Profiles
15.1 Cook Medical
15.1.1 Company Overview
15.1.2 Company Snapshot
15.1.3 Product Overview
15.1.4 Business Overview
15.1.5 SWOT Analysis
15.1.6 Recent Developments
15.2 Coopersurgical Inc.
15.2.1 Company Overview
15.2.2 Company Snapshot
15.2.3 Product Overview
15.2.4 Business Overview
15.2.5 SWOT Analysis
15.2.6 Recent Developments
15.3 Corning Inc.
15.3.1 Company Overview
15.3.2 Company Snapshot
15.3.3 Product Overview
15.3.4 Business Overview
15.3.5 SWOT Analysis
15.3.6 Recent Developments
15.4 Eppendorf SE
15.4.1 Company Overview
15.4.2 Company Snapshot
15.4.3 Product Overview
15.4.4 Business Overview
15.4.5 SWOT Analysis
15.4.6 Recent Developments
15.5 Esco Micro Pte. Ltd.
15.5.1 Company Overview
15.5.2 Company Snapshot
15.5.3 Product Overview
15.5.4 Business Overview
15.5.5 SWOT Analysis
15.5.6 Recent Developments
15.6 FertiPro NV
15.6.1 Company Overview
15.6.2 Company Snapshot
15.6.3 Product Overview
15.6.4 Business Overview
15.6.5 SWOT Analysis
15.6.6 Recent Developments
15.7 FUJIFILM Irvine Scientific, Inc.
15.7.1 Company Overview
15.7.2 Company Snapshot
15.7.3 Product Overview
15.7.4 Business Overview
15.7.5 SWOT Analysis
15.7.6 Recent Developments
15.8 Hamilton Thorne, Inc.
15.8.1 Company Overview
15.8.2 Company Snapshot
15.8.3 Product Overview
15.8.4 Business Overview
15.8.5 SWOT Analysis
15.8.6 Recent Developments
15.9 Irvine Scientific
15.9.1 Company Overview
15.9.2 Company Snapshot
15.9.3 Product Overview
15.9.4 Business Overview
15.9.5 SWOT Analysis
15.9.6 Recent Developments
15.10 IVFtech ApS
15.10.1 Company Overview
15.10.2 Company Snapshot
15.10.3 Product Overview
15.10.4 Business Overview
15.10.5 SWOT Analysis
15.10.6 Recent Developments
15.11 Kitazato Corp.
15.11.1 Company Overview
15.11.2 Company Snapshot
15.11.3 Product Overview
15.11.4 Business Overview
15.11.5 SWOT Analysis
15.11.6 Recent Developments
15.12 Laboratoire CCD
15.12.1 Company Overview
15.12.2 Company Snapshot
15.12.3 Product Overview
15.12.4 Business Overview
15.12.5 SWOT Analysis
15.12.6 Recent Developments
15.13 Labotect GmbH
15.13.1 Company Overview
15.13.2 Company Snapshot
15.13.3 Product Overview
15.13.4 Business Overview
15.13.5 SWOT Analysis
15.13.6 Recent Developments
15.14 Merck KGaA
15.14.1 Company Overview
15.14.2 Company Snapshot
15.14.3 Product Overview
15.14.4 Business Overview
15.14.5 SWOT Analysis
15.14.6 Recent Developments
15.15 Microtech IVF S.r.o.
15.15.1 Company Overview
15.15.2 Company Snapshot
15.15.3 Product Overview
15.15.4 Business Overview
15.15.5 SWOT Analysis
15.15.6 Recent Developments
15.16 Nidacon International AB
15.16.1 Company Overview
15.16.2 Company Snapshot
15.16.3 Product Overview
15.16.4 Business Overview
15.16.5 SWOT Analysis
15.16.6 Recent Developments
15.17 Nikon Instruments Inc.
15.17.1 Company Overview
15.17.2 Company Snapshot
15.17.3 Product Overview
15.17.4 Business Overview
15.17.5 SWOT Analysis
15.17.6 Recent Developments
15.18 Thermo Fisher Scientific Inc.
15.18.1 Company Overview
15.18.2 Company Snapshot
15.18.3 Product Overview
15.18.4 Business Overview
15.18.5 SWOT Analysis
15.18.6 Recent Developments
15.19 Vitrolife AB
15.19.1 Company Overview
15.19.2 Company Snapshot
15.19.3 Product Overview
15.19.4 Business Overview
15.19.5 SWOT Analysis
15.19.6 Recent Developments
15.20 Zeiss Group
15.20.1 Company Overview
15.20.2 Company Snapshot
15.20.3 Product Overview
15.20.4 Business Overview
15.20.5 SWOT Analysis
15.20.6 Recent Developments

16 Appendix
16.1 Self-Assessment Form

Companies Mentioned

  • Cook Medical
  • Coopersurgical Inc.
  • Corning Inc.
  • Eppendorf SE
  • Esco Micro Pte. Ltd.
  • FertiPro NV
  • FUJIFILM Irvine Scientific, Inc.
  • Hamilton Thorne, Inc.
  • Irvine Scientific
  • IVFtech ApS
  • Kitazato Corp.
  • Laboratoire CCD
  • Labotect GmbH 
  • Merck KGaA
  • Microtech IVF S.r.o.
  • Nidacon International AB
  • Nikon Instruments Inc.
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB
  • Zeiss Group